Frost Radar™: Microbiome Therapeutics, 2020

Frost Radar™: Microbiome Therapeutics, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

RELEASE DATE
09-Dec-2020
REGION
Global
Research Code: D9C1-01-00-00-00
SKU: HC03363-GL-TR_25021

$4,950.00

Special Price $4,207.50 save 15 %

In stock
SKU
HC03363-GL-TR_25021

$4,950.00

$4,207.50 save 15 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurring microbiota is actively involved in metabolic cycle and the performance of immune system. Today, with deeper understanding of microbiome and its role in human health, we are able to utilize microbiome for developing therapeutics. Designing microbial therapeutics has been challenging , however with the help of genetic engineering tools manipulating these naturally occurring consortia of microbiome has gained momentum in the last five years. Numerous studies are being conducted to gain deeper understanding of host-microbiome interaction for developing targeted therapeutics.A significant focus of human microbiome research has been studying the bacteria in the gut, which represent the largest community both in terms of abundance and diversity. Microbiome therapeutics companies are increasingly involved in developing therapies for dysbiosis , obesity, inflammatory bowel disease, cancer, even neurological disorders as schizophrenia and autism.
This Frost Radar profiles companies actively involved in developing microbiome therapeutics.

Table of Contents

Strategic Imperative

Growth Environment

Growth Environment (Continued)

Frost Radar™: Microbiome Therapeutics

Frost Radar™

Frost Radar™

4D Pharma PLC

ENTEROME

Finch Therapeutics

Intralytix

Locus Biosciences

Microbiotica

Second Genome

Seres Therapeutics

Rebiotix- Ferring Pharmaceuticals

Vedanta Biosciences

Strategic Insights

Significance of Being on the Frost Radar™

Frost Radar™ Empowers the CEO’s Growth Team

Frost Radar™ Empowers Investors

Frost Radar™ Empowers Customers

Frost Radar™ Empowers the Board of Directors

Frost Radar™: Benchmarking Future Growth Potential

Frost Radar™: Benchmarking Future Growth Potential

Legal Disclaimer

Related Research
Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurring microbiota is actively involved in metabolic cycle and the performance of immune system. Today, with deeper understanding of microbiome and its role in human health, we are able to utilize microbiome for developing therapeutics. Designing microbial therapeutics has been challenging , however with the help of genetic engineering tools manipulating these naturally occurring consortia of microbiome has gained momentum in the last five years. Numerous studies are being conducted to gain deeper understanding of host-microbiome interaction for developing targeted therapeutics.A significant focus of human microbiome research has been studying the bacteria in the gut, which represent the largest community both in terms of abundance and diversity. Microbiome therapeutics companies are increasingly involved in developing therapies for dysbiosis , obesity, inflammatory bowel disease, cancer, even neurological disorders as schizophrenia and autism. This Frost Radar profiles companies actively involved in developing microbiome therapeutics.
More Information
No Index No
Podcast No
Author Neeraja Vettekudath
Industries Healthcare
WIP Number D9C1-01-00-00-00
Is Prebook No